Biosynex S.A. (ALBIO) is a Medical diagnostics research company in the Healthcare sector, listed on Euronext Paris. This page provides the complete earnings calendar, dividend schedule, and financial data for Biosynex S.A. in 2026.
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
Latest earnings analysis
Consensus estimates were not available, and Biosynex S.A. posted revenue of usd 267.06 million while EPS was not disclosed. No prior report data is available for comparison on EPS or revenue.
No dividend history available.
Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.
Biosynex S.A. (ALBIO) last reported earnings on October 20, 2021.
Biosynex S.A. (ALBIO) is listed on Euronext Paris.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.